What are the recommendations for the treatment of seasonal allergic rhinitis (SAR) in adolescents and adults?

Updated: Jun 04, 2021
  • Author: Jack M Becker, MD; Chief Editor: Harumi Jyonouchi, MD  more...
  • Print
Answer

In 2017, the Joint Task Force on Practice Parameters (JTFPP) released updated recommendations for the treatment of seasonal allergic rhinitis (SAR) in adolescents and adults. [16]

Updated guidelines include the following:

  • In patients aged 12 years or older, nasal symptoms of SAR should be treated at least initially with an intranasal corticosteroid (INCS) alone rather than an INCS–oral antihistamine combination.

  • In patients aged 15 years or older, moderate to severe SAR should be treated with an INCS over a leukotriene receptor antagonist (LTRA).

  • Clinicians may recommend combination therapy with an INCS and an intranasal antihistamine (INAH) over either agent alone.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!